pd 98059 has been researched along with perylene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Romerio, F; Zella, D | 1 |
| Burd, MA; Peterson, DG; Strong, ME | 1 |
2 other study(ies) available for pd 98059 and perylene
| Article | Year |
|---|---|
MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b.
Topics: Anthracenes; CD4-Positive T-Lymphocytes; Cell Cycle; Cell Division; Drug Synergism; Enzyme Inhibitors; Flavonoids; Humans; Interferon alpha-2; Interferon-alpha; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Perylene; Proto-Oncogene Proteins c-raf; ras Proteins; Recombinant Proteins; Signal Transduction; Time Factors | 2002 |
Evaluation of the MA-10 cell line as a model of insl3 regulation and Leydig cell function.
Topics: Animals; Cell Line; Chorionic Gonadotropin; Flavonoids; Gene Expression Regulation; Insulin; Isoquinolines; Leydig Cells; Male; Mice; Nuclear Receptor Subfamily 4, Group A, Member 1; Perylene; Proteins; Signal Transduction; Sulfonamides; Testosterone; Wortmannin | 2019 |